Page last updated: 2024-11-12

neanthine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

neanthine: structure; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12521357
SCHEMBL ID164277
MeSH IDM0052225

Synonyms (40)

Synonym
methoxyethyl mercuric chloride
emisan 6
beta-methoxyethylmercury chloride
atiran
higosan
vegoll
tafasan 6w
mercury, chloro(2-methoxyethyl)-
chloro(2-methoxyethyl)mercury
emisan
2-methoxyethylmercuric chloride
(beta-methoxyethyl)mercuric chloride
brn 4123443
tafasan
2-methoxyethylmerkurichlorid [czech]
tayssato
merchlorate
methoxyaethylquecksilberchlorid [german]
methoxyethylmercury chloride
aretan 6
memc
agallolat
ccris 5835
gramisan
neanthine
agallo forte
ceresan universal wet
ceranit 6
aretan
einecs 204-659-7
sedresan
2-methoxyethylmercury chloride
123-88-6
2-methoxyethylmerkurichlorid
unii-8j3u131744
methoxyaethylquecksilberchlorid
SCHEMBL164277
methoxyethylmercuric chloride
(2-methoxyethyl)mercury(ii) chloride
2-methoxyethyl-mercury-chloride

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"05 times more toxic than mercuric chloride (HgCl2) and emisan 6 (methoxyethyl mercury chloride), respectively, for 96 hr."( Toxic effects of three mercurial compounds on survival, and histology of the kidney of the catfish Clarias batrachus (L.).
Joy, KP; Kirubagaran, R, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (80.00)18.7374
1990's1 (6.67)18.2507
2000's2 (13.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (6.25%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]